Bristol Myers Squibb Co (BMY) EPS (Basic) (2009 - 2026)
Bristol Myers Squibb (BMY) posted quarterly EPS (Basic) of $1.62 for Q2 2026, up 151.69% year-over-year from $0.65 in Q2 2025, and up 23.54% quarter-over-quarter from $1.31 in Q1 2026.
Bristol Myers Squibb Co (BMY) EPS (Basic) (2009 - 2026) Analysis & Trends
Bristol Myers Squibb (BMY) has reported EPS (Basic) for 18 consecutive years, with $1.62 the latest figure, recorded in Q2 2026.
- In Q2 2026, EPS (Basic) rose 151.69% year-over-year to $1.62; the TTM figure through Jun 2026 stood at $4.54 (up 82.48% YoY), while the FY2025 annual figure was $3.47, up 178.72% from the prior year.
- EPS (Basic) advanced to $1.62 in Q2 2026 per BMY's latest filing, from $1.31 in the prior quarter.
- Across five years, EPS (Basic) topped out at $1.62 in Q2 2026 and bottomed at -$5.89 in Q1 2024.
- Historically, EPS (Basic) has averaged $0.49 across 5 years, with a median of $0.84 in 2024.
- Annual changes were most pronounced in 2024 — EPS (Basic) slumped 645.01% — and 2025, when it jumped 1324.03%.
- Bristol Myers Squibb's EPS (Basic) stood at $0.95 in 2022, then dropped by 10.42% to $0.85 in 2023, then sank by 95.6% to $0.04 in 2024, then soared by 1324.03% to $0.53 in 2025, then soared by 204.14% to $1.62 in 2026.
- Business Quant data shows BMY's EPS (Basic) at $1.62 in Q2 2026, $1.31 in Q1 2026, and $0.53 in Q4 2025.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.62 |
| Mar 31, 2026 | 1.31 |
| Dec 31, 2025 | 0.53 |
| Sep 30, 2025 | 1.08 |
| Jun 30, 2025 | 0.65 |
| Mar 31, 2025 | 1.21 |
| Dec 31, 2024 | 0.04 |
| Sep 30, 2024 | 0.60 |
| Jun 30, 2024 | 0.83 |
| Mar 31, 2024 | -5.89 |
| Dec 31, 2023 | 0.85 |
| Sep 30, 2023 | 0.94 |
| Jun 30, 2023 | 0.99 |
| Mar 31, 2023 | 1.08 |
| Dec 31, 2022 | 0.95 |
| Sep 30, 2022 | 0.75 |
| Jun 30, 2022 | 0.67 |
| Mar 31, 2022 | 0.60 |
| Dec 31, 2021 | 1.07 |
| Sep 30, 2021 | 0.70 |